Search filters
Filters
Clear All

Phase

  • 10
  • 10
  • 10
  • 10

Found 10 Barrett's Esophagus trials

A listing of Barrett's Esophagus medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

UPCC 25420: Expanded Access Protocol (EAP) for Patients Receiving Lisocabtagene Maraleucel that is Nonconforming for Commercial Release

99 years and younger
All genders
This study is available to subjects who have previously agreed to receive lisocabtagene maraleucel. The lisocabtagene maraleucel T cells for those subjects that were produced do not meet all of the prespecified release criteria to be used as a routine prescription drug as required by the governing health authority-- this …
Learn More

URBI Study

99 years and younger
All genders
Primary Objective: Determine if high definition white light colonoscopy (HDWLC) using a limited biopsy strategy is non-inferior to HDWLC using a random biopsy strategy to detect dysplasia or sessile serrated adenoma (SSA) in patients with IBD. Secondary objectives: 1. Determine if HDWLC using a limited biopsy strategy is superior to …
Learn More

UPCC 13419: An Open-Label, Phase 1/2 Study of JCAR017 in Subjects with Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (017004)

99 years and younger
All genders
The purpose of this study is to evaluate the safety, recommended dose, antitumor activity, and pharmacokinetics of JCAR017 in subjects with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma. The safety of JCAR017 in subjects who are receiving concurrent ibrutinib will also be evaluated.
Learn More

Aqueous Humor Proteomics

99 years and younger
All genders
PURPOSE The goal of this study is to measure the levels of over 11,000 proteins in the aqueous humor and correlate it with single-cell transcriptomics data. This will improve understanding of the molecular mechanisms and cell types contributing to dry AMD, POAG, and Stargardts disease. This will allow us to …
Learn More

UPCC 15120: A Phase III Double-blind Randomised Study Assessing the Efficacy and Safety of Capivasertib + Paclitaxel Versus Placebo + Paclitaxel as First-line Treatment for Patients with Histologically Confirmed, Locally Advanced (Inoperable) or Metastat

99 years and younger
All genders
The purpose of this study is to find out if capivasertib given with paclitaxel is an effective treatment for triple negative breast cancer (TNBC). As part of this study subjects will receive paclitaxel in combination with either capivasertib or a placebo. Eligible subjects will be those diagnosed with metastatic (or …
Learn More

HBCD Study

99 years and younger
All genders
We are requesting a reliance agreement with CHOP. CHOP IRB will be relying on the central site's IRB at the University of California San Diego. UCSD is the regulatory entity that the NIH has chosen to oversee all IRB aspects of this study. This study will prospectively examine human brain, …
Learn More

ACV01

99 years and younger
All genders
A randomized, multi-site, adaptive, open-label clinical trial to determine whether autoimmune disease pts who receive the alternate vaccine for their COVID booster vaccine [RNA then vector-based or vice versa] have a better increase in anti-COVID-19 antibody response (Spike) compared to those who receive the same vaccine booster as their initial …
Learn More

ICE-OSA

99 years and younger
All genders
The primary objectives of this study are to establish if there is a relationship between successful treatment of OSA with the Cryosa Procedure and baseline quantity of oropharyngeal fat, baseline pharyngeal opening pressure (PhOP), and baseline tongue position and tongue motion. Secondary objectives of this study include assessing whether quantity …
Learn More

RESTORE Study

99 years and younger
All genders
The primary objective of this study is to assess whether there is sufficient evidence of improved fatigue among patients with Crohns disease taking CoQ10 to warrant conduct of a larger, placebo-controlled clinical trial. The primary outcome will be measured with the PROMIS Fatigue 7a, a unidimensional scale that has been …
Learn More

ROMA: Women

99 years and younger
All genders
The primary aim is to conduct a multicenter international randomized control trial to test the hypothesis that the use of a two or more AGs compared to a single arterial graft is associated with a reduction in the composite outcome of death from any cause, any stroke, post discharge myocardial …
Learn More